Clinical trials

Participating in a clinical trial can have several benefits in improving cancer management. Here are a few examples:

• Access to new treatments : clinical trials allow patients to access new treatments that are not yet available or that are not yet approved by regulatory authorities. This may offer an additional treatment option for patients who have not responded to other treatments or who have no other treatment options available.
• Access to specialized research teams : possessing in-depth expertise on your pathology will provide you with support, care and advice with close follow-up.
• Reduction in side effects : clinical trials can allow the patient to benefit from experimental treatments that aim to be more effective, more specific and have fewer side effects than current treatments. This can therefore lead to a potential improvement in the patient’s quality of life.

These potential benefits may vary depending on the treatment being studied, the patient’s health condition, and other factors. It is important to talk to your doctor about the potential benefits of participating in a clinical trial.

More generally, participation in a clinical trial can contribute to the advancement of medical research and help improve treatments for new patients. Past and current scientific advances have only been possible thanks to the participation of healthy and ill volunteers in clinical research. Any treatment prescribed by a doctor has previously been the subject of a clinical trial.

A cohort in a clinical trial refers to a Specific group of participants in a clinical research study who share certain characteristicsor specific inclusion criteria or receive the intervention according to a specific modality. Clinical trials may have one or more cohorts, depending on the purpose of the study and the complexity of the disease.

In so-called comparative trials (e.g. phase 3 trial), the results of the clinical trial are generally analyzed by comparing the results of the cohort receiving the experimental treatment (called interventional group) with those of a control group that receives either the reference treatment or the placebo (in the absence of a validated standard treatment).

For therapeutic trials that test a drug, a phase 4 clinical trial is a study that is conducted after the treatment has been approved and marketed. Medications continue to be monitored strictly over the long term, so-called post-AMM, in order to gather information on the long-term effectiveness and safety of treatment, in particular by examining rare side effects that may not have been detected in previous phases (Pharmacovigilance).

Phase 4 trials may also be intended to evaluate this new approved drug under different administration conditions, for example the frequency of administration, the number of courses, the duration of the infusion...